Ste Adwya SA is a Tunisia-based company engaged in the provision of generic and licensed pharmaceuticals for human and veterinary use. The Company’s range of products spans several medical areas, including cardiology, dermatology, neuro-psychiatry, metabolism and nutrition, diabetes and urology, among others. It offers drugs traded under the brand name: Novadol, Anxiomyl, Celiprol, Enapril, Glimid, Mesatec, Spirazol and Celopram, among others; drugs manufactured under license agreements with GlaxoSmithkline, Solvay, Sanofi-Aventis, Abbot, and Astra Zeneca, among others, and drugs prepared for third party laboratories. The Company operates two production sites: Alpha, which manufactures the non-penicillin products, and Beta, which specializes in the production of antibiotics. The new branch of activity launched by the Company is the natural therapy range, API-AR and multivitamins range, Advita multivitamins. In February 2014, it established a subsidiary Adwya Promotion Cote d'Ivoire.